businesspress24.com - BioExx Specialty Proteins Announces Change in Management
 

BioExx Specialty Proteins Announces Change in Management

ID: 1258994

(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 08/29/13 -- BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX: BXI), today announced that its board of directors (the "Board") has appointed John MacDonald, currently a director of the Company, to serve as Interim Chief Executive Officer of the Company. The Board wishes to express its gratitude to Chris Schnarr, the previous Chief Executive Officer of the Company, who has also resigned from the Board.

Mr. MacDonald is Managing Director of John MacDonald and Associates, a firm of established accounting and tax professionals he founded in 1989 after several years in senior management positions with the Government of Ontario. Serving in various roles including CEO, Chairman, and Chief Restructuring Officer, Mr. MacDonald has leveraged his leadership and professional experience to lead change and growth strategies at several companies. Mr. MacDonald has been a director of BioExx since April 2008.

About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is focused on the separation of oil and high-value proteins from oilseeds for global food, beverage, nutrition, and other markets. BioExx employs trade secret, patented and patent-pending technologies to enable the improved separation of proteins from oilseeds. BioExx believes that these processes cumulatively have the potential to make a valuable contribution to global food and protein supply while maintaining an environmentally sustainable footprint.

To find out more about BioExx Specialty Proteins Ltd. (TSX: BXI), please visit .

The statements made in this press release include forward-looking statements that involve a number of risks and uncertainties. These statements relate to future events or future performance and reflect management's current expectations and assumptions. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, such as the economy, generally, competition in its target markets, the demand for BioExx's products, the availability of funding, the efficacy of its technology, and the anticipated costs of BioExx's plant construction and operation. These forward-looking statements are made as of the date hereof and BioExx does not assume any obligation to update or revise them to reflect new events or circumstances. Actual events or results could differ materially from BioExx's expectations and projections.







Contacts:
BioExx Specialty Proteins Ltd.
John MacDonald
Interim Chief Executive Officer
(416) 588-4442


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  China Will Retain Dominance of Solar Industry Despite Looming Shakeout
Vista Partners Updates Coverage on Power Solutions International, Inc.; Price Target Raised to $60.00
Bereitgestellt von Benutzer: Marketwired
Datum: 29.08.2013 - 05:30 Uhr
Sprache: Deutsch
News-ID 1258994
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

TORONTO, ONTARIO


Phone:

Kategorie:

Alternative Energy


Anmerkungen:


Diese Pressemitteilung wurde bisher 128 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"BioExx Specialty Proteins Announces Change in Management
"
steht unter der journalistisch-redaktionellen Verantwortung von

BioExx Specialty Proteins Ltd. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von BioExx Specialty Proteins Ltd.



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 63


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.